VACCINE MANUFACTURING AND INNOVATION CENTRE UK LIMITED

Trading Name: VMIC

Registered office: 30 Finsbury Square, London, EC2A 1AG

Principal trading address: Building B587 Curie Avenue, Harwell Campus, Didcot, OX11 0RH

Nature of Business: Manufacture of pharmaceuticals

Final Date for Proving: 7 September 2022.

Notice is hereby given, pursuant to rule 14.29 of the Insolvency (England and Wales) Rules 2016, that the Joint Liquidators intend to declare a first interim dividend to the unsecured non preferential creditors of the Company within the period of two months from the last date for proving, being 7 September 2022.

Creditors who have not yet done so must prove their debts by delivering their proofs (in the format specified in rule 14.4) to the Joint Liquidators to the address detailed below no later than the last date for proving.

Creditors who have not proved their debt by the final date for proving may be excluded from the benefit of this dividend or any other dividend declared before their debt is proved.

Liquidator's Name and Address: Sean K Croston (IP No. 8930) of Grant Thornton UK LLP, 30 Finsbury Square, London, EC2A 1AG. Telephone: 020 7184 4300

Liquidator's Name and Address: Richard G White (IP No. 8937) of Grant Thornton UK LLP, 30 Finsbury Square, London, EC2A 1AG. Telephone: 020 7184 4300

Date of Appointment: 27 April 2022.

For further information contact Julian H Berry at the offices of Grant Thornton UK LLP on 0113 200 1604, or Julian.H.Berry@uk.gt.com.

29 July 2022.

For further information contact Julian H Berry at the offices of Grant Thornton UK LLP on 0113 200 1604, or Julian.H.Berry@uk.gt.com.

28 July 2022